Table 1.

Vaccines administered at each vaccination time point and outcome assessment in the three study groups

Allocation	Follow up time following enrolment
	Week 0	Week 1	Week 4	Week 24	Week 28
Group A (Single dose)	Strata 1 and 3: Vi-DT Strata 2: Vi-DT plus TRIMOVAX®† All Strata: Immediate safety	Safety assessment	Safety and immunogenicity assessment	All Strata: FluQuadri™ All Strata: Immediate safety	Safety and immunogenicity
Group B (Two dose)				All Strata: Vi-DT All Strata: Immediate safety a
Group C (Comparator)	Strata 1 and 3: Placebo‡ Strata 2: TRIMOVAX®† All Strata: Immediate safety			All Strata: FluQuadri™ and Immediate safety

Age Stratum 1 (6 to <9months); Age Stratum 2 (9 to 12 months); Age Stratum 3 (13-23 months).

^†TRIMOVAX® – attenuated measles, mumps and rubella (MMR) vaccine was given to children between the ages of 9-12 months.

^‡Placebo for Age Strata 1 and 3 at enrolment was normal saline injection.